ASSURA PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.88 GBX | -0.05% |
|
+0.54% | -15.05% |
| Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
| Mar. 20 | Which Powell will we get? |  |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests and treatments in the community. The Company is a long-term property partner to more than 600 medical centers. The Company owns and manages a portfolio of about 607 properties. Its subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, and others.
Sector
Specialized REITs
Calendar
2024-05-15
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
0.4088
GBP
Average target price
0.507
GBP
Spread / Average Target
+24.02%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.05% | 1.52B | |
| +4.25% | 55.38B | |
| -13.00% | 17.56B | |
| -7.37% | 13.22B | |
| +0.78% | 7.58B | |
| -16.54% | 5.49B | |
| +7.02% | 3.21B | |
| -4.34% | 3.17B | |
| -6.99% | 3.04B | |
| -7.13% | 2.77B |
- Stock Market
- Equities
- AGR Stock
- News Assura Plc
- Assura : JPMorgan Downgrades Assura to Neutral from Overweight
